Feature

Rox Medical announced enrollment of the first U.K. patients in the CONTROL-HTN international randomized controlled trial of the Rox Flow procedure for the treatment of resistant hypertension.

Home April 01, 2013
Home
Toshiba, activation imaging, ACC, 2013
Feature | Dave Fornell

This is a roundup of some of the DAIC editor's choice of the most innovative new technologies showcased at ACC 2013, including products in the areas of interventional cardiology, patient monitoring, electrophysiology and echocardiography.

Home March 28, 2013
Home
News

Cardiologists at ACC.13 learned that patients with coronary artery disease who received a Resolute drug-eluting stent from Medtronic Inc. as participants in one of several clinical studies and interrupted or discontinued their dual antiplatelet therapy after one month of the implant procedure showed no increased safety risk through one year of follow-up.

Home March 28, 2013
Home
Feature

Thoratec Corp. announced that it has successfully completed the first human use of HeartMate PHP (percutaneous heart pump). The first PHP patient was supported for over 60 minutes during a high-risk percutaneous coronary intervention (HR PCI). The patient was hemodynamically stable during the procedure, which involved three-vessel intervention on a patient with an ejection fraction less than 30 percent. Two additional patients were treated as part of this first-in-man series. The procedures were performed by Adrian Ebner, M.D. at Sanatorio Italiano in Asuncion, Paraguay. Ebner is the chief of the Cardiovascular Department at Sanatorio Italiano.

Home March 28, 2013
Home
Feature

St. Jude Medical announced publication of results from its landmark RESPECT clinical trial in The New England Journal of Medicine.

Home March 28, 2013
Home
Feature

Minimally invasive procedures significantly lower health payer costs and result in fewer missed workdays when compared to open surgery, according to a study published this week in the Journal of the American Medical Association (JAMA) Surgery. Of six procedures examined, the percutaneous coronary intervention (PCI) arm of the study drove the cost savings. This is an important finding, considering that heart disease remains the leading cause of death and disability in the United States and accounts for considerable expenditures in healthcare services, medications and lost productivity.

Home March 28, 2013
Home
News

A new test that detects asymptomatic individuals who may be at risk for cardiovascular disease is being launched in Europe at the Healthcare Innovation Expo 2013. The device, known as AngioDefender, was developed by Everist Genomics Inc. of Ann Arbor, Mich., in collaboration with scientists at Rutgers University, New Jersey. The developers claim that the test will lower the cost of detecting and treating cardiovascular problems and improve patient outcomes.

Home March 27, 2013
Home
Biotronik Iforia ICD/CRT-D CE-Approval
Feature

Biotronik received CE mark for its most advanced ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device) series. Iforia is the world’s first DF4 ICD/CRT-D series approved for MRI (magnetic resonance imaging). In addition it contains one of the world’s smallest ICDs, the Iforia single chamber ICD.

Home March 27, 2013
Home
News

The Heart Failure 2013 LA meeting will include a showcase of several startup companies offering innovative new approaches to address heart and cardiovascular disease.

Home March 27, 2013
Home
News

The U.S. Food and Drug Administration (FDA) notified healthcare professionals of a Class I recall of the Vascular Solutions Inc. Guardian II and Guardian II NC Hemostasis Valves. The firm is recalling the product due to a risk that air may be introduced into the device which may lead to an air embolism. This product may cause serious adverse health consequences, including death.

Home March 27, 2013
Home
Sponsored Content | Videos | Blood Pressure Monitor

SunTech demonstrated its new Tango M2 cardiac stress test automated blood pressure monitoring system at the American ...

Home March 26, 2013
Home
Technology

FujiFilm Medical Systems U.S.A. Inc. showcased its Synapse 3D at the American College of Cardiology (ACC) conference March 9 to 11, 2013 at the Moscone Center in San Francisco, Calif. Fully integrated with Synapse Cardiovascular, Synapse 3D will appeal to cardiologists and cardiovascular specialists interested in advanced visualization and analysis for their diagnostic needs.

Home March 26, 2013
Home
News

March 26, 2013 — According to two different reports from Millennium Research Group (MRG), the overall European market for peripheral vascular devices will grow strongly, reaching $1.3 billion by 2017. Increases in endovascular procedures, along with innovations such as drug-coated balloons (DCB), aortic stent grafts and chronic total occlusion (CTO) crossing devices, will support revenue growth.

Home March 26, 2013
Home
News

NeuroVive announces that the 600th patient has been recruited to a pivotal Phase III European, multi-center clinical trial (CIRCUS trial) assessing CicloMulsion (a special formulation of cyclosporine for acute cardiac injuries) for the treatment of heart reperfusion injury following stenting in patients with myocardial infarction.

Home March 26, 2013
Home
News

March 26, 2013 — A multicenter analysis, led by Weill Cornell Medical College and published in the Journal of Clinical Gastroenterology, shows the use of temporary "fully covered self-expanding metal stents" (FCSEMS) can effectively fix a painful and potentially life-threatening benign biliary stricture.

Home March 26, 2013
Home
Subscribe Now